A Study of Pembrolizumab/Vibostolimab in Relapsed/Refractory Hematological Malignancies
The purpose of the study is to determine the safety and tolerability of pembrolizumab/vibostolimab (MK-7684A) in hematological malignancies. This study will also evaluate the overall response rate (ORR), the duration of